Download video

Long-Term Safety of Trofinetide for Rett Syndrome in Younger Children (2-4 years)

156 views

CheckRare

7 months ago

Long-Term Safety of Trofinetide for Rett Syndrome in Younger Children (2-4 years)

Long-Term Safety of Trofinetide for Rett Syndrome in Younger Children (2-4 years)

Long-Term Safety of Trofinetide for Rett Syndrome in Younger Children (2-4 years)
8:36
Long-Term Safety of Trofinetide for Rett Syndrome in Younger Children (2-4 years)
by CheckRare
What is DAYBUE? - What You Need to Know About DAYBUE (trofinetide), Part 1
26:13
What is DAYBUE? - What You Need to Know About DAYBUE (trofinetide), Part 1
by International Rett Syndrome Foundation
IRSF Parent Panel: My Trofinetide Clinical Trial Experience
1:01:26
IRSF Parent Panel: My Trofinetide Clinical Trial Experience
by International Rett Syndrome Foundation
Long-Term Data of Trofinetide in Patients With Rett Syndrome
10:30
Long-Term Data of Trofinetide in Patients With Rett Syndrome
by CheckRare
Implementing the Second International Guidelines for BK Polyomavirus in Kidney Transplantation
59:42
Implementing the Second International Guidelines for BK Polyomavirus in Kidney Transplantation
by ESOTtransplant
HER2 Testing in NSCLC: Key Insights and Treatment Strategies | Module 2
16:14
HER2 Testing in NSCLC: Key Insights and Treatment Strategies | Module 2
by i3 Health
RettEd: Physical Therapy Goals in Rett Syndrome and Benefits of Aquatherapy
27:57
RettEd: Physical Therapy Goals in Rett Syndrome and Benefits of Aquatherapy
by International Rett Syndrome Foundation
How and Why Does Daybue Work in Rett Syndrome?
26:24
How and Why Does Daybue Work in Rett Syndrome?
by Midwest Rett Syndrome Foundation
Health Headlines: Breakthrough drug may stop progression of Rett Syndrome
2:06
Health Headlines: Breakthrough drug may stop progression of Rett Syndrome
by KPLC 7 News
4R Health Talk 2 Latest advances in the treatment of hematological malignancies
1:11:28
4R Health Talk 2 Latest advances in the treatment of hematological malignancies
by 4R Talk
Long-Term Data of Trofinetide in Patients With Rett Syndrome
8:11
Long-Term Data of Trofinetide in Patients With Rett Syndrome
by CheckRare
Tom Beer, MD, explains whether PFS2 is a legitimate endpoint in prostate cancer clinical trials
0:44
Tom Beer, MD, explains whether PFS2 is a legitimate endpoint in prostate cancer clinical trials
by OBRoncology
Safety and anti-tumor activity of BAY 2927088 in patients with HER2-mutant NSCLC
1:40
Safety and anti-tumor activity of BAY 2927088 in patients with HER2-mutant NSCLC
by VJOncology
Trofinetide for the Treatment of Rett Syndrome
13:23
Trofinetide for the Treatment of Rett Syndrome
by CheckRare
Phase II study of fixed-duration obinutuzumab, ibrutinib \& venetoclax in elderly patients with RT
2:03
Phase II study of fixed-duration obinutuzumab, ibrutinib \& venetoclax in elderly patients with RT
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53
1:34
Brightline-2: brigimadlin as a 2L treatment for advanced cancers with MDM2 amplification and wtTP53
by VJOncology